Tag: Helen Collins

Five Prime, Zai Lab initiate phase 3 trial of bemarituzumab chemo combo

pharmanewsdaily- October 1, 2018

Five Prime Therapeutics and Zai Lab have dosed the first patient in a phase 3 study of bemarituzumab (FPA144) in combination with chemotherapy in patients ... Read More